13 July 2012
The four district health boards across the Northern Region have celebrated a patient safety milestone, with no cases of central line-associated bacteraemia (CLAB) recorded in April.
It was part of a national achievement that saw no CLAB event in any intensive care unit across the country for the entire month.
The region’s DHBs are participating in a national CLAB collaborative to ensure adhering to best practice reduces infection risks to our patients.
Counties Manukau DHB CEO and Northern Region Health Plan Executive Sponsor Geraint Martin said the CLAB-free month was proof that patient safety projects led out of the Northern Region could pay ‘huge dividends’.
“That puts us very much up there at the forefront of change and at the forefront of delivering improvement,” he said whilst opening the First, Do No Harm campaign’s Learning Session One event in Auckland.
“We can do this. If we put our minds to it and feel confident enough about it, link into the best, most effective methodologies, people like you – through this plan, through this process – can really make a big, big impact on the world around us.”
First, Do No Harm Clinical Lead Karen O’Keeffe said April’s ‘zero’ result reflected the DHBs’ commitment to improving patient safety and minimising preventable harm during care.
“We all recognise that there is a need to provide safer care and to work together on initiatives that have the potential to achieve this,” Karen said.
“That’s what the First, Do No Harm campaign is all about and it’s very encouraging to see tangible signs of improvement against our target of reducing CLAB by 40 per cent across region.”
The region recorded nine cases of CLAB from January to March, including a peak of four in February.
“We need to always remember that each case of CLAB results in much longer average length of hospital stay for patients and has a real impact on their lives and on the lives of those close to them,” Karen said.
“Every time we prevent a CLAB infection by taking steps that have been proven to significantly reduce the risk of infection, there are a number of positive outcomes.
“Critically, we spare patients an adverse experience that will take them a long time to get over and, in some cases, may even prove fatal.
“We also improve productivity, free-up capacity in the hospital system and save the cost of providing care to a patient with a CLAB infection.”